Mortality After Acute Coronary Syndrome in Human Immunodeficiency Virus Infection with Optimal Adherence: A Nationwide Study
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: There have been few studies on the outcome of acute coronary syndrome (ACS) in human immunodeficiency virus (HIV) infection in the era when antiretroviral therapy (ART) is generalized and most of them have achieved viral suppression. Using claims data, we aimed to assess the mortality after atherosclerotic cardiovascular events in people with HIV (PWH) who maintain optimal adherence to ART. Materials and Methods: We used claims data from the National Health Insurance of the Korea to confirm newly diagnosed PWH from 2009 to 2019, and measured ART adherence. ACS and mortality were confirmed in PWH who showed optimal adherence to ART. Results: Among 7,100 PWH with optimal adherence and during 27,387 person-year of follow-up duration, ACS was confirmed in 140 (2.0%) cases, which was 1.3 times greater than statistics of the Korean general population (511.0 vs. 383.1 per 100,000). Acquired immunodeficiency syndrome, hypertension, dyslipidemia, and diabetes mellitus were associated with the development of ACS in PWH with optimal adherence. Mortality was confirmed in 10 cases, which is 7.1% overall and 2.9% when limited to myocardial infarction. It was comparable with the mortality rate of the Korean general population after myocardial infarction (8.9%). Conclusion: ACS prevalence was higher in PWH even when optimal adherence was maintained. However, mortality after ACS was comparable to that in the HIV-negative population.
Abstract
Background: There have been few studies on the outcome of acute coronary syndrome (ACS) in human immunodeficiency virus (HIV) infection in the era when antiretroviral therapy (ART) is generalized and most of them have achieved viral suppression. Using claims data, we aimed to assess the mortality after atherosclerotic cardiovascular events in people with HIV (PWH) who maintain optimal adherence to ART. Materials and Methods: We used claims data from the National Health Insurance of the Korea to confirm newly diagnosed PWH from 2009 to 2019, and measured ART adherence. ACS and mortality were confirmed in PWH who showed optimal adherence to ART. Results: Among 7,100 PWH with optimal adherence and during 27,387 person-year of follow-up duration, ACS was confirmed in 140 (2.0%) cases, which was 1.3 times greater than statistics of the Korean general population (511.0 vs. 383.1 per 100,000). Acquired immunodeficiency syndrome, hypertension, dyslipidemia, and diabetes mellitus were associated with the development of ACS in PWH with optimal adherence. Mortality was confirmed in 10 cases, which is 7.1% overall and 2.9% when limited to myocardial infarction. It was comparable with the mortality rate of the Korean general population after myocardial infarction (8.9%). Conclusion: ACS prevalence was higher in PWH even when optimal adherence was maintained. However, mortality after ACS was comparable to that in the HIV-negative population.
참고문헌 (24)
- Triant VA, "Cardiovascular disease and HIV infection", Curr HIV, 2013, pp.10, 199~206
- Hsue PY, "HIV infection and coronary heart disease : mechanisms and management", Nat Rev Cardiol, 16, pp.745~759 (2019)
- Freiberg MS, "HIV infection and the risk of acute myocardial infarction", JAMA Intern Med, 173, pp.614~622 (2013)
- Feinstein MJ, "Patterns of cardiovascular mortality for HIV-infected adults in the United States : 1999 to 2013", Am J Cardiol, 117, pp.214~220 (2016)
- Pearce D, "Comparison of in-hospital mortality from acute myocardial infarction in HIV sero-positive versus seronegative individuals", Am J Cardiol, 110, pp.1078~1084 (2012)
- Lorgis L, "Outcomes after acute myocardial infarction in HIV-infected patients : analysis of data from a French nationwide hospital medical information database", Circulation, 127, pp.1767~1774 (2013)
- Palella FJ Jr, "Mortality in the highly active antiretroviral therapy era : changing causes of death and disease in the HIV outpatient study", J Acquir Immune Defic Syndr, 43, pp.27~34 (2006)
- Feinstein MJ, "Mortality following myocardial infarction among HIV-infected persons : the Center for AIDS Research Network Of Integrated Clinical Systems(CNICS)", BMC Med, 17, pp.149~ (2019)
- Bozzette SA, "Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection", N Engl J Med, 348, pp.702~710 (2003)
- Trickey A, "Cause-specific mortality in HIV-positive patients who survived ten years after starting antiretroviral therapy", PLoS One, 11, pp.e0160460~ (2016)
- Castillo-Mancilla JR, "Association of incomplete adherence to antiretroviral therapy with cardiovascular events and mortality in virologically suppressed persons with HIV : The Swiss HIV cohort study", Open Forum Infect Dis, 8, pp.ofab032~ (2021)
- Alonso A, "HIV infection and incidence of cardiovascular diseases : an analysis of a large healthcare database", J Am Heart Assoc, 8, pp.e012241~ (2019)
- Hyeok-Hee Lee, "Korea Heart Disease Fact Sheet 2020: Analysis of Nationwide Data", Korean Circulation Journal, 51(6), pp.495~503 (2021), 대한심장학회[DOI]
- 김희진, "Validity of the Diagnosis of Acute Myocardial Infarction in Korean National Medical Health Insurance Claims Data: The Korean Heart Study (1)", Korean Circulation Journal, 42(1), pp.10~15 (2012), 대한심장학회
- Kim J, "Adherence to antiretroviral therapy and factors affecting low medication adherence among incident HIV-infected individuals during 2009-2016 : A nationwide study", Sci Rep, 8, pp.3133~ (2018)
- Choi Hyohun, "Impact of the COVID-19 Pandemic on Patient Delay and Clinical Outcomes for Patients With Acute Myocardial Infarction", Journal of Korean Medical Science, 37(21), pp.1~12 (2022), 대한의학회[DOI]
- "Health at a Glance 2021: OECD indicators. Mortality following acute myocardial infarction (AMI)" (2021)[URL]
- Hsue PY, "HIV infection and coronary heart disease : mechanisms and management", Nat Rev Cardiol, 16, pp.745~759 (2019)
- Nou E, "Inflammation, immune activation, and cardiovascular disease in HIV", AIDS, 30, pp.1495~1509 (2016)
- Osibogun O, "HIV", HCV coinfection and the risk of cardiovascular disease : A meta-analysis, 2017, pp.24, 998~1004
- Zuccalà P, "Longitudinal assessment of multiple immunological and inflammatory parameters during successful DAA therapy in HCV monoinfected and HIV", HCV coinfected subjects, 2022, pp.23, 11936~
- Parks MM, "Longitudinal management and outcomes of acute coronary syndrome in persons living with HIV infection", Eur Heart J Qual Care Clin Outcomes, 7, pp.273~279 (2021)
- "Parks M. Postdischarge outcomes following acute coronary syndrome in HIV" (2020)[URL]
- Hanna DB, "Trends in nonlipid cardiovascular disease risk factor management in the women’s interagency HIV study and association with adherence to antiretroviral therapy", AIDS Patient Care STDS, 30, pp.445~454 (2016)